1. Home
  2. NTWK vs DYAI Comparison

NTWK vs DYAI Comparison

Compare NTWK & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • DYAI
  • Stock Information
  • Founded
  • NTWK 1997
  • DYAI 1979
  • Country
  • NTWK United States
  • DYAI United States
  • Employees
  • NTWK N/A
  • DYAI N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NTWK Technology
  • DYAI Health Care
  • Exchange
  • NTWK Nasdaq
  • DYAI Nasdaq
  • Market Cap
  • NTWK 34.9M
  • DYAI 30.2M
  • IPO Year
  • NTWK 1998
  • DYAI 2004
  • Fundamental
  • Price
  • NTWK $3.03
  • DYAI $0.96
  • Analyst Decision
  • NTWK
  • DYAI Strong Buy
  • Analyst Count
  • NTWK 0
  • DYAI 1
  • Target Price
  • NTWK N/A
  • DYAI $3.00
  • AVG Volume (30 Days)
  • NTWK 94.3K
  • DYAI 132.8K
  • Earning Date
  • NTWK 11-12-2025
  • DYAI 11-12-2025
  • Dividend Yield
  • NTWK N/A
  • DYAI N/A
  • EPS Growth
  • NTWK N/A
  • DYAI N/A
  • EPS
  • NTWK 0.04
  • DYAI N/A
  • Revenue
  • NTWK $66,501,654.00
  • DYAI $3,342,195.00
  • Revenue This Year
  • NTWK N/A
  • DYAI $18.18
  • Revenue Next Year
  • NTWK N/A
  • DYAI $87.65
  • P/E Ratio
  • NTWK $74.42
  • DYAI N/A
  • Revenue Growth
  • NTWK 7.70
  • DYAI N/A
  • 52 Week Low
  • NTWK $2.14
  • DYAI $0.71
  • 52 Week High
  • NTWK $5.75
  • DYAI $2.20
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 32.71
  • DYAI 43.62
  • Support Level
  • NTWK $2.80
  • DYAI $0.90
  • Resistance Level
  • NTWK $3.16
  • DYAI $1.00
  • Average True Range (ATR)
  • NTWK 0.21
  • DYAI 0.09
  • MACD
  • NTWK -0.01
  • DYAI 0.00
  • Stochastic Oscillator
  • NTWK 20.25
  • DYAI 47.50

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: